If approved, it could have the potential to reshape how severe hypoglycemia is treated. -Craig Idlebrook/GluCraig UPDATE – 7/25/2018 – Lilly clarifies that they are asking for the FDA and the EMA to approve this drug for both people with both type 1 diabetes and people with type 2 diabetes to use. Nasal glucagon is going […]
Apple Watch - New Features That Might Interest People with Type 1 Diabetes
Better blood glucose tracking, fall detection, and heart monitoring.